Disclosures regarding Declaration of Interim Dividend, Record Date for Interim Dividend, Issuance of Bonus Shares and Allotment of Equity Shares under Thyrocare Employee Stock Option Scheme of the Company.
Grant Of Employee Stock Options Under Thyrocare Employee Stock Option Scheme.
Disclosure under Regulation 30A of LODR
Intimation regarding the appointment of Mr. Rahul Guha, Managing Director and Chief Executive Officer of the Company, as Managing Director and Chief Executive Officer of API Holdings Limited, Ultimate Holding Company.
Change of Code of Conduct of the Company of the Regulating, Monitoring and Reporting of Trading by Designated Persons and their Immediate Relatives under the SEBI (Prohibition of Insider Trading) Regulations, 2015.
Change in Directorate
Change in Chief Financial Officer (CFO)
Record Date Intimation for final Dividend
Disclosure Under Regulation 30 of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
Closure of Trading Window – July 01, 2025
Newspaper advertisements – June 17, 2025
Additional Equity infusion in Thyrocare Laboratories (Tanzania) Limited – Joint Venture – June 03, 2025
Allotment of 996 Equity Shares pursuant to the Employee Stock Option Scheme (ESOS) of the Company
Appointment of Secretarial Auditors and Re-appointment of Cost Auditor
Closure of Trading Window – April 01, 2025
Additional Equity infusion in Thyrocare Laboratories (Tanzania) Limited – Joint Venture
Authority for determining material events and making disclosures in relation to Regulation 30(5) of the Listing Regulations
Appointment of Mr. Brijesh Kumar as Company Secretary, Compliance Officer and Key Managerial Personnel of the Company wef January 31, 2025.
Retirement of Mr. Ramjee Dorai as Company Secretary and Compliance Officer of the Company wef January 31, 2025.
Allotment of 1651 Equity Shares pursuant to the Employee Stock Option Scheme (ESOS) of the Company
Grant of options under Thyrocare Employees Stock Option Scheme
Intimation of allotment of equity shares of the Company under “Thyrocare Employee Stock Option Scheme”.
Equity Infusion In Thyrocare Laboratories (Tanzania) Limited
Appointment of Mr. Amey Joshi as Vice President – Human Resources
News Paper Publication
Completion Of Business Transfer Agreement With Vimta Labs Limited
Closure of Trading Window
Cessation of Independent Director
Press Release “Thyrocare Technologies Limited enters into a Business Transfer Agreement to acquire diagnostic and pathological services business of Vimta Labs Limited”.
Execution Of Business Transfer Agreement With Vimta Labs Limited.
